Luminous Ventures Closes $730M+ in Dual-Currency Funds, China's Largest VC Raise of 2026
TL;DR
Luminous Ventures, the firm formerly known as Lightspeed China Partners, has closed over $730 million across two new dual-currency funds, making it the largest VC fundraise in China so far in 2026. The oversubscribed sixth USD fund landed at $460 million, while the third RMB fund achieved a first close of roughly $139 million against a $293 million target. With nearly 10 IPOs expected this year and a portfolio that includes Unitree Robotics and Zhipu, this raise signals that top-tier China-focused VCs can still attract serious global institutional capital despite geopolitical headwinds.
Key Takeaways
China VC fundraising market is bifurcating sharply. While mid-tier Chinese funds struggle to raise capital in a post-ZIRP world, Luminous is proving that elite early-stage managers with strong DPI can still command oversubscribed rounds from sovereign wealth funds, endowments, and pensions across the US, Europe, Asia, and the Middle East.
The Lightspeed rebrand is now backed by numbers. When Luminous Ventures dropped the Lightspeed China Partners name in October 2025, skeptics wondered whether independence would hurt fundraising. This $730M+ raise is the definitive answer: the brand transition has had zero negative impact on LP appetite.
A pipeline of roughly 10 IPOs in 2026 is extraordinary. The portfolio includes Zhipu (HKD 400B+ market cap at IPO), Unitree Robotics (STAR Market), and METiS Pharmaceuticals (Hong Kong). That kind of near-term liquidity is the ultimate LP magnet and explains why the USD fund was oversubscribed.
Dual-currency structure is becoming the dominant model for China VC. With the RMB fund backed by government-guided funds and industrial investors, and the USD fund attracting global institutions, Luminous has built a structure that can deploy into both policy-aligned domestic opportunities and globally competitive Chinese-led ventures.
Fund Overview
Fund Name: Luminous Ventures Fund VI (USD) + Fund III (RMB)
Fund Size: $460M (USD, final close) + ~$139M first close / $293M target (RMB) = $730M+ total
Stage: Early-stage
Check Size: Not disclosed
Geography: China-focused with global reach
Focus: Technology, AI, deep tech, robotics, healthcare
Key LPs: Sovereign wealth funds, university endowments, global pension funds, fund-of-funds, family offices, tech corporates (USD). Government-guided funds, industrial investors, institutional capital (RMB).
Why This Fund Matters
The China VC market in 2026 is defined by extreme polarization. Capital commitments to Chinese venture funds have dropped significantly from their 2021-2022 peaks, driven by geopolitical tensions, US-China decoupling fears, and a sluggish domestic IPO market. Most mid-tier Chinese VCs are facing brutal fundraising environments, with many unable to reach even first close on new vehicles.
Luminous Ventures exists on the other side of this divide. By closing north of $730 million across two funds, the firm has demonstrated that track record and near-term liquidity trump macro anxiety. The secret sauce is straightforward: when your portfolio is producing IPOs at scale, LPs will find a way to wire money.
The dual-currency approach is strategically important. The RMB fund allows Luminous to participate in China's most policy-sensitive sectors, including AI chips, embodied intelligence, and advanced manufacturing, where foreign capital faces increasing regulatory scrutiny. The USD fund, meanwhile, gives global LPs exposure to China's innovation economy through a manager with deep local networks and a proven track record of exits.
Perhaps most importantly, this raise is a data point for the broader China VC ecosystem. It suggests that the LP pullback from China is not universal but selective. Managers with demonstrable DPI and near-term exit pipelines can still raise at scale. The rest are being left behind.
The Team
Luminous Ventures is led by founding partner Mi Qun, who established the firm's predecessor, Lightspeed China Partners, as the China arm of Silicon Valley's Lightspeed Venture Partners. The firm rebranded to Luminous Ventures in October 2025 to reflect its full operational independence. The team has built a portfolio of over 200 companies across AI, robotics, enterprise software, healthcare, and consumer technology, with a strong concentration in frontier technology categories that align with China's industrial policy priorities.
Early Portfolio
Luminous Ventures' portfolio is deep and increasingly liquid. Recent exits include Hanshow Technology and Moore Threads via IPO. Zhipu, the large language model company, went public with a market capitalization exceeding HKD 400 billion. The firm expects nearly 10 portfolio companies to IPO in 2026, with Unitree Robotics (embodied intelligence/robotics, targeting STAR Market) and METiS Pharmaceuticals (AI drug discovery, targeting Hong Kong) among the most anticipated listings.
What This Means for Founders
If you are building in AI, robotics, deep tech, or healthcare in China or as a Chinese entrepreneur globally, Luminous should be on your shortlist. The firm's dual-currency structure means it can write checks in either USD or RMB depending on your corporate structure and regulatory situation, which is increasingly important for Chinese startups navigating the VIE/WFOE decision.
Beyond capital, Luminous brings the credibility of the former Lightspeed China brand, deep relationships across the Chinese tech ecosystem, and a clear path to IPO support given its active pipeline. For founders targeting STAR Market, HKEX, or even US listings, having a GP with recent successful exits on all three exchanges is a material advantage.
Fund Momentum Take
This is a statement raise. In a market where the narrative has been relentlessly negative on China VC, Luminous Ventures just pulled in three-quarters of a billion dollars and oversubscribed its USD vehicle. That does not happen by accident, and it does not happen for managers coasting on brand alone.
The roughly 10-company IPO pipeline for 2026 is the real story here. DPI is everything right now. LPs globally are starved for actual distributions, and a manager that can credibly promise near-term liquidity events at scale will always find demand for its next fund. Luminous has that, and the fundraise reflects it.
The risk? China's regulatory environment remains unpredictable, and geopolitical tensions could complicate exits for portfolio companies seeking US or dual listings. But for a manager that has navigated these waters successfully for over a decade, these are known risks with known mitigation strategies. We expect Luminous to fully close its RMB fund well above target.
Frequently Asked Questions
What is Luminous Ventures?
Luminous Ventures is a China-focused early-stage venture capital firm previously known as Lightspeed China Partners. It rebranded in October 2025 to reflect its full independence from Lightspeed Venture Partners.
How much did Luminous Ventures raise?
The firm raised over $730 million across two vehicles: a $460 million oversubscribed USD fund (Fund VI) and an RMB fund (Fund III) with a first close of approximately $139 million, targeting $293 million total.
What does Luminous Ventures invest in?
The firm focuses on early-stage technology companies across AI, robotics, deep tech, enterprise software, and healthcare, with a particular emphasis on Chinese founders and China-market opportunities.
Who are the LPs in Luminous Ventures?
USD fund LPs include sovereign wealth funds, university endowments, global pension funds, fund-of-funds, family offices, and tech corporates from the US, Europe, Asia, and the Middle East. RMB fund LPs include government-guided funds, industrial investors, and institutional capital.
What companies has Luminous Ventures backed?
Notable portfolio companies include Zhipu (LLMs, HKD 400B+ market cap), Unitree Robotics (embodied intelligence), METiS Pharmaceuticals (AI drug discovery), Hanshow Technology, and Moore Threads, among others.
Have a fund closing to announce? Submit your fund here.
Need help raising capital? Check out our Fundraising Advisory services.